Le cluster Lopinavir (therapeutic use) - Ritonavir (therapeutic use)
| 000048 (2020) | H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000825 (2020) | Hongzhou Lu [République populaire de Chine] | Drug treatment options for the 2019-new coronavirus (2019-nCoV). |
| 000A18 (2020) | Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine] | Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. |
| 000049 (2020) | B. Du [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; X. Zhan [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; X Y Li [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; Z H Tong [République populaire de Chine] | [Pharmacotherapeutics for the New Coronavirus Pneumonia]. |
| 000222 (2020) | Guangdi Li ; Erik De Clercq | Therapeutic options for the 2019 novel coronavirus (2019-nCoV). |
| 000402 (2020) | Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro |
| 000564 (2020) | Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
| 000A58 (2020) | Jaegyun Lim [Corée du Sud] ; Seunghyun Jeon [Corée du Sud] ; Hyun-Young Shin [Corée du Sud] ; Moon Jung Kim [Corée du Sud] ; Yu Min Seong [Corée du Sud] ; Wang Jun Lee [Corée du Sud] ; Kang-Won Choe [Corée du Sud] ; Yu Min Kang [Corée du Sud] ; Baeckseung Lee [Corée du Sud] ; Sang-Joon Park [Corée du Sud] | Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR |
| 000C06 (2020) | Eric J. Rubin ; Lindsey R. Baden ; Stephen Morrissey | Audio Interview: New Research on Possible Treatments for Covid-19. |
| 000060 (2020) | M L Sun [République populaire de Chine] ; J M Yang [République populaire de Chine] ; Y P Sun [République populaire de Chine] ; G H Su [République populaire de Chine] | [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]. |
| 000217 (2020) | David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000220 (2020) | Robert L. Kruse [États-Unis] | Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. |
| 000615 (2020) | Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis] | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. |
| 000826 (2020) | Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash Medhi | Drug targets for corona virus: A systematic review |
| 000A37 (2020) | Ewen Callaway ; David Cyranoski | China coronavirus: Six questions scientists are asking. |
| 000075 (2020) | J P Zhao ; Y. Hu ; R H Du ; Z S Chen ; Y. Jin ; M. Zhou ; J. Zhang ; J M Qu ; B. Cao | [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]. |
| 000330 (2020) | Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
| 000545 (2020) | Huan Liang [République populaire de Chine] ; Ganesh Acharya [Suède] | Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow? |
| 000661 (2020) | Deng-Hai Zhang [République populaire de Chine] ; Kun-Lun Wu [République populaire de Chine] ; Xue Zhang [République populaire de Chine] ; Sheng-Qiong Deng [République populaire de Chine] ; Bin Peng [République populaire de Chine] | In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. |
| 000834 (2020) | Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine] | Discovering drugs to treat coronavirus disease 2019 (COVID-19). |
| 000A07 (2020) | Clark D. Russell [Royaume-Uni] ; Jonathan E. Millar [Royaume-Uni] ; J Kenneth Baillie [Royaume-Uni] | Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. |
| 000B95 (2020) | Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine] | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. |
| 001159 (2014) | Mohammad Khalid ; Basha Khan ; Fahad Al Rabiah ; Ruwaida Alismaili ; Sarfraz Saleemi ; Agha Muhammad Rehan-Khaliq ; Ihab Weheba ; Hail Al Abdely ; Magid Halim ; Quaid Johar Nadri ; Abdullah Mohsin Al Dalaan ; Mohamed Zeitouni ; Taimur Butt ; Eid Al Mutairy | Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia |
| 000032 (2020) | X. Yuan [République populaire de Chine] ; J S Mu [République populaire de Chine] ; G X Mo [République populaire de Chine] ; X S Hu [République populaire de Chine] ; P. Yan [République populaire de Chine] ; L X Xie [République populaire de Chine] | [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy]. |
| 000050 (2020) | Y N Liu [République populaire de Chine] | [Pharmacotherapeutic about the new coronavirus pneumonia]. |
| 000057 (2020) | Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine] | [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. |
| 000077 (2020) | [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. | |
| 000090 (2020) | L. Zhou [République populaire de Chine] ; H G Liu | [Early detection and disease assessment of patients with novel coronavirus pneumonia]. |
| 000264 (2020) | Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine] | The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. |
| 000430 (2020) | Dale Fisher [Singapour] ; David Heymann [Royaume-Uni] | Q&A: The novel coronavirus outbreak causing COVID-19 |
| 000480 (2020) | Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine] | Potential interventions for novel coronavirus in China: A systematic review. |
| 000507 (2020) | G. Kampf [Allemagne] ; D. Todt [Allemagne] ; S. Pfaender [Allemagne] ; E. Steinmann [Allemagne] | Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. |
| 000581 (2020) | Fei Yu [République populaire de Chine] ; Lanying Du [États-Unis] ; David M. Ojcius [États-Unis] ; Chungen Pan [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] | Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. |
| 000769 (2020) | Heshui Shi ; Xiaoyu Han ; Chuansheng Zheng | Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China. |
| 000828 (2020) | Shibo Jiang | Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. |
| 000857 (2020) | Yaseen M. Arabi [Arabie saoudite] ; Robert Fowler [Canada] ; Frederick G. Hayden [États-Unis] | Critical care management of adults with community-acquired severe respiratory viral infection |
| 000C59 (2020) | Ying-Hui Jin [République populaire de Chine] ; Lin Cai [République populaire de Chine] ; Zhen-Shun Cheng [République populaire de Chine] ; Hong Cheng [République populaire de Chine] ; Tong Deng [République populaire de Chine] ; Yi-Pin Fan [République populaire de Chine] ; Cheng Fang [République populaire de Chine] ; Di Huang [République populaire de Chine] ; Lu-Qi Huang [République populaire de Chine] ; Qiao Huang [République populaire de Chine] ; Yong Han [République populaire de Chine] ; Bo Hu [République populaire de Chine] ; Fen Hu [République populaire de Chine] ; Bing-Hui Li [République populaire de Chine] ; Yi-Rong Li [République populaire de Chine] ; Ke Liang [République populaire de Chine] ; Li-Kai Lin [République populaire de Chine] ; Li-Sha Luo [République populaire de Chine] ; Jing Ma [République populaire de Chine] ; Lin-Lu Ma [République populaire de Chine] ; Zhi-Yong Peng [République populaire de Chine] ; Yun-Bao Pan [République populaire de Chine] ; Zhen-Yu Pan [République populaire de Chine] ; Xue-Qun Ren [République populaire de Chine] ; Hui-Min Sun [République populaire de Chine] ; Ying Wang [République populaire de Chine] ; Yun-Yun Wang [République populaire de Chine] ; Hong Weng [République populaire de Chine] ; Chao-Jie Wei [République populaire de Chine] ; Dong-Fang Wu [République populaire de Chine] ; Jian Xia [République populaire de Chine] ; Yong Xiong [République populaire de Chine] ; Hai-Bo Xu [République populaire de Chine] ; Xiao-Mei Yao [Canada] ; Yu-Feng Yuan [République populaire de Chine] ; Tai-Sheng Ye [République populaire de Chine] ; Xiao-Chun Zhang [République populaire de Chine] ; Ying-Wen Zhang [République populaire de Chine] ; Yin-Gao Zhang [République populaire de Chine] ; Hua-Min Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Ming-Juan Zhao [République populaire de Chine] ; Hao Zi [République populaire de Chine] ; Xian-Tao Zeng [République populaire de Chine] ; Yong-Yan Wang [République populaire de Chine] ; Xing-Huan Wang [République populaire de Chine] | A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). |
| 001885 (2001) | S. Braun [Allemagne] ; J. Ramaker ; E. Dippel ; C C Zouboulis | [Schonlein-Henoch purpura associated with hepatitis B in a patient with HIV infection]. |
| This area was generated with Dilib version V0.6.33. |  |